Group 1 - The company does not currently have products directly used in solid-state batteries, but its sodium carbonate and phosphate products are basic raw materials for some solid-state battery cathodes [1] - The company holds a 50% stake in Nigeria's BCT Company through its wholly-owned subsidiary, Hebang Bio (Hong Kong) Investment Co., Ltd [1] - BCT Company is primarily engaged in the mining, washing, and sales of lithium and tin ores, currently holding exploration rights for 15 lithium mines and 6 tin mines [1] Group 2 - BCT Company controls 60% of "Deep Earth Mineral Resources Limited," which has exploration rights for 5 lithium mines, and "BC Mining Company Limited," which has exploration rights for 2 lithium mines [1]

Core Points - Hebang Biotechnology announced the need to pay corporate income tax and late fees totaling 71,473,969.37 yuan for the period from January 1, 2023, to December 31, 2023 [1] - As of the date of the announcement, the company has completed the payment of the aforementioned tax and late fees, and this matter does not involve any administrative penalties [1]

Market Performance - The agricultural chemical sector increased by 0.64% on September 11, with Dongfang Tieta leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] Stock Performance - Dongfang Tieta (002545) closed at 12.96, up 6.23% with a trading volume of 487,700 shares and a transaction value of 623 million [1] - Bai'ao Chemical (603360) closed at 25.20, up 2.56% with a trading volume of 150,100 shares and a transaction value of 373 million [1] - Other notable stocks include Yaji International (000893) at 38.46, up 2.04%, and Beisimei (300796) at 10.53, up 2.03% [1] Capital Flow - The agricultural chemical sector experienced a net outflow of 281 million from institutional investors, while retail investors saw a net inflow of 153 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Yanhai Co. (000792) had a net inflow of 99.18 million from institutional investors, while it faced a net outflow of 62.99 million from speculative funds [3] - Bai'ao Chemical (603360) saw a net inflow of 18.38 million from institutional investors but a net outflow of 24.29 million from speculative funds [3] - Guotian Co. (002170) had a net inflow of 8.12 million from institutional investors, with a significant net inflow of 46.84 million from speculative funds [3]

和邦生物（603077）(603077.SH)发布公告，经自查，公司需补缴2023年1月1日至2023年12月31日企业 所得税及滞纳金合计7147.4万元。截至本公告披露日，公司已将上述税款及滞纳金缴纳完毕，本事项不 涉及行政处罚。 公司补缴上述税款及滞纳金将计入2025年当期损益，预计将影响公司2025年度归属于上市公司股东的净 利润7147.4万元，最终以2025年度经审计的财务报表为准。 ...

和邦生物(603077.SH)发布公告，经自查，公司需补缴2023年1月1日至2023年12月31日企业所得税及滞 纳金合计7147.4万元。截至本公告披露日，公司已将上述税款及滞纳金缴纳完毕，本事项不涉及行政处 罚。 公司补缴上述税款及滞纳金将计入2025年当期损益，预计将影响公司2025年度归属于上市公司股东的净 利润7147.4万元，最终以2025年度经审计的财务报表为准。 ...

| 证券代码：603077 | 证券简称：和邦生物 | 公告编号：2025-043 | | --- | --- | --- | | 债券代码：113691 | 债券简称：和邦转债 | | 四川和邦生物科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 09 月 15 日（星期一）至 09 月 19 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jsy@hebang.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 四川和邦生物科技股份有限公司（以下简称"公司"）已于 2025 年 8 月 20 日发布《四川和邦生物科技股份有限公司 2025 年半年度报告》，为便于广大投资 者更全面深入地了解公司 2025 年半年度经营成果、财务状况，公司计划于 2025 年 09 月 22 日（星期一）16:00-17:00 举行 2025 年半年度业绩说明会，就投资 者关心的问题进 ...

证券代码：603077 证券简称：和邦生物 公告编号：2025-042 债券代码：113691 债券简称：和邦转债 四川和邦生物科技股份有限公司 关于公司补缴税款的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、对公司的影响 根据《企业会计准则第 28 号--会计政策、会计估计变更和差错更正》相关 规定，上述补缴税款及滞纳金事项不属于前期会计差错，不涉及前期财务数据追 溯调整。公司补缴上述税款及滞纳金将计入 2025 年当期损益，预计将影响公司 2025 年度归属于上市公司股东的净利润 71,473,969.37 元，最终以 2025 年度经 审计的财务报表为准。 特此公告。 四川和邦生物科技股份有限公司董事会 2025 年 9 月 12 日 四川和邦生物科技股份有限公司（以下简称"公司"）根据税法相关规定对 涉税业务开展了自查，现将有关情况公告如下： 一、基本情况 经自查，公司需补缴 2023 年 1 月 1 日至 2023 年 12 月 31 日企业所得税及滞 纳金合计 71,473,969.37 元。截至本公告 ...

Group 1 - The company, Hebang Biology (603077.SH), announced that it needs to pay a total of 71.474 million yuan in corporate income tax and late fees for the period from January 1, 2023, to December 31, 2023 [1] - As of the date of the announcement, the company has completed the payment of the aforementioned tax and late fees [1] - This matter does not involve any administrative penalties [1]

Group 1 - The company has completed the registration of its overseas investment project in Nigeria, holding a 50% stake in BULLCREST MINERAL RESOURCES LIMITED (BCT), which focuses on lithium and tin mining [1][2] - BCT currently possesses exploration rights for 15 lithium mines and 6 tin mines, along with additional rights through its subsidiaries [1] - The company has received the necessary approvals from the Sichuan Provincial Development and Reform Commission and the Sichuan Provincial Department of Commerce for its overseas investment [2] Group 2 - The overseas investment project is located in Kwara State, Nigeria, with a 50% ownership split between the company and AFRICORP HOLDINGS LIMITED [2] - The company acknowledges potential risks associated with the new operating environment, including cultural, legal, and policy-related challenges, and emphasizes the importance of risk assessment and management [2]

Group 1 - The company, Hebang Biology, announced that it holds a 50% stake in Nigeria's BULLCREST MINERAL RESOURCES LIMITED (BCT) through its wholly-owned subsidiary, Hebang Biology (Hong Kong) Investment Co., Ltd [2] - BCT, established in 2023 under Nigerian federal law, is primarily engaged in the mining, washing, and sales of lithium and tin ores, currently holding 15 lithium and 6 tin mining exploration rights [2] - The company has completed the registration of its overseas investment and received the Overseas Investment Project Filing Notification from the Sichuan Provincial Development and Reform Commission [2]